What Exactly Is GAMMORA and How Does It Help?
Developed by Code Pharma, GAMMORA is designed to block HIV by destroying infected cells and replacing them with healthy CD4 cells, as demonstrated in clinical trials. The treatment uses a synthetic peptide that forces infected cells to self-destruct without harming healthy ones.
Gammora is a synthetic 16-amino-acid peptide, derived from HIV-1 integrase and initially discovered at the Hebrew University in Israel. The company is conducting in-vitro, animal, and clinical studies to confirm its safety and efficacy, while also exploring methods to ensure patient-friendly drug delivery.
Learn More About GAMMORA
GAMMORA's Mechanisem Explained
Gammora is a lab-engineered 16-amino-acid peptide derived from HIV-1 integrase, originally discovered at the Hebrew University in Israel. It disrupts a mechanism that typically inhibits the penetration of viral DNA fragments, triggering apoptosis in infected cells while leaving healthy cells unharmed. Unlike antiretrovirals, which suppress HIV DNA integration, Gammora eradicates HIV-infected cells and gradually restores healthy CD4 cells, offering the potential for a true cure for AIDS rather than just managing it as a chronic condition.
Latest News
BioSpace: Code Pharma’s Gammora Shows Promising Results Toward an HIV Cure
Code Pharma reported encouraging eight-week results for its HIV drug, Gammora, highlighting its potential to target HIV at the cellular level. The findings were shared
BusinessWire: Code Pharma’s Gammora Shows Promising Results as a Potential HIV Cure
Code Pharma has reported encouraging eight-week results for its HIV drug, Gammora, suggesting a potential to eradicate the virus at the cellular level. As published
Gammora by Code Pharma Shows Strong Potential in HIV Cure Research
Code Pharma announced positive results from an eight-week clinical trial of Gammora, suggesting the drug’s potential to target HIV at the cellular level. Preliminary findings
Code Pharma Set to Present Promising GAMMORA HIV Treatment Breakthroughs
As published by ‘pressat’, Code Pharma, a Netherlands-based pharmaceutical company, is preparing to showcase groundbreaking findings on GAMMORA, a drug aimed at treating HIV, at